Science Explorer Back to mapMap
Discussion
Company · Copenhagen · Denmark

Novo Nordisk (Denmark)

In research, Novo Nordisk (Denmark) stands highest in Health Sciences (#538 of 9,902 worldwide), Medicine (#578 of 8,541 worldwide) and Life Sciences (#526 of 6,403 worldwide), 2022-now. Relative to its size it is most specialised in Endocrinology, Diabetes and Metabolism and Hematology (Endocrinology, Diabetes and Metabolism is 31.8× its share of world research).

novonordisk.comROR OpenAlex
World rank, 2022-now
#1,045
of 22,385 · #1,485 all time
Rank in Denmark
#9
of 93
Research works
6.8k
▲ 28% vs 2018-21
Citations
263k
38.4 per fractional work
Top-10% rate
16.2%
all institutions 10.0%
vs its own fields
1.23×
1.00× is exactly expected
Open access
41%
world 40%
International
44%
world 18%
Novo Nordisk (Denmark)

What is Novo Nordisk (Denmark) known for in research?

The fields where it stands highest, 2022-now, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
Health SciencesDomain #538 of 9,902 16.3%514 #774
MedicineField #578 of 8,541 16.6%478 #848
Life SciencesDomain #526 of 6,403 19.7%194 #665
Biochemistry, Genetics and Molecular BiologyField #380 of 2,964 19.3%141 #534
Molecular BiologySubfield #327 of 1,880 17.2%96 #505
Endocrinology, Diabetes and MetabolismSubfield #75 of 349 14.2%154 #168
Physical SciencesDomain #2,616 of 10,670 11.9%101 #5457
Social SciencesDomain #4,283 of 9,585 8.8%79 #7769

Each strip is that field's whole ranked pool, with the notch where Novo Nordisk (Denmark) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no average mark, because the average differs by field (from about 6% in Dentistry to 21% in Economics).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022-now. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Health Sciences#774 #538
  2. Medicine#848 #578
  3. Life Sciences#665 #526
  4. Biochemistry, Genetics and Molecular Biology#534 #380
  5. Molecular Biology#505 #327
  6. Endocrinology, Diabetes and Metabolism#168 #75
  7. Physical Sciences#5,457 #2,616
  8. Social Sciences#7,769 #4,283
all time2022-now, better2022-now, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

Which fields of science does Novo Nordisk (Denmark) work in?

In 2022-now, 58% of research at Novo Nordisk (Denmark) is in Health Sciences, 22% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (16%), Engineering (4%). It does 2.5× the world's share of Health Sciences.

Health Sciences: 584 fractional works · 57.7% of its workMedicine: 545 fractional works · 53.8% of its workEndocrinology, Diabetes and Metabolism: 175 fractional works · 17.3% of its workSurgery: 56 fractional works · 5.6% of its workCardiology and Cardiovascular Medicine: 36 fractional works · 3.6% of its workEpidemiology: 33 fractional works · 3.3% of its workHematology: 33 fractional works · 3.2% of its workPhysiology: 31 fractional works · 3.0% of its workPulmonary and Respiratory Medicine: 17 fractional works · 1.7% of its workPublic Health, Environmental and Occupational Health: 16 fractional works · 1.6% of its workGenetics: 15 fractional works · 1.4% of its workPharmacology: 14 fractional works · 1.4% of its workOncology: 13 fractional works · 1.3% of its workRadiology, Nuclear Medicine and Imaging: 13 fractional works · 1.3% of its workPsychiatry and Mental health: 13 fractional works · 1.3% of its workPediatrics, Perinatology and Child Health: 11 fractional works · 1.1% of its workNephrology: 10 fractional works · 1.0% of its workRheumatology: 8 fractional works · 0.7% of its workPathology and Forensic Medicine: 7 fractional works · 0.7% of its workHepatology: 6 fractional works · 0.6% of its workFamily Practice: 6 fractional works · 0.6% of its workNeurology: 5 fractional works · 0.5% of its workObstetrics and Gynecology: 4 fractional works · 0.4% of its workInfectious Diseases: 3 fractional works · 0.3% of its workGeriatrics and Gerontology: 3 fractional works · 0.3% of its workSmaller subfields together: 15 fractional works · 1.5% of its workHealth Professions: 32 fractional works · 3.2% of its workGeneral Health Professions: 14 fractional works · 1.4% of its workPharmacy: 12 fractional works · 1.1% of its workHealth Information Management: 3 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.3% of its workNursing: 5 fractional works · 0.5% of its workNutrition and Dietetics: 5 fractional works · 0.5% of its workVeterinary: 1 fractional works · 0.1% of its workDentistry: 0 fractional works · 0.0% of its workLife Sciences: 226 fractional works · 22.4% of its workBiochemistry, Genetics and Molecular Biology: 164 fractional works · 16.2% of its workMolecular Biology: 111 fractional works · 10.9% of its workGenetics: 32 fractional works · 3.1% of its workCell Biology: 5 fractional works · 0.5% of its workCancer Research: 5 fractional works · 0.5% of its workBiophysics: 4 fractional works · 0.4% of its workBiotechnology: 3 fractional works · 0.3% of its workSmaller subfields together: 5 fractional works · 0.5% of its workNeuroscience: 24 fractional works · 2.3% of its workCellular and Molecular Neuroscience: 8 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 8 fractional works · 0.8% of its workNeurology: 3 fractional works · 0.3% of its workCognitive Neuroscience: 3 fractional works · 0.3% of its workSmaller subfields together: 2 fractional works · 0.2% of its workImmunology and Microbiology: 18 fractional works · 1.8% of its workImmunology: 17 fractional works · 1.7% of its workSmaller subfields together: 1 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 11 fractional works · 1.1% of its workPharmaceutical Science: 7 fractional works · 0.7% of its workPharmacology: 2 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.2% of its workAgricultural and Biological Sciences: 10 fractional works · 1.0% of its workFood Science: 4 fractional works · 0.4% of its workPlant Science: 4 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.3% of its workPhysical Sciences: 116 fractional works · 11.4% of its workEngineering: 38 fractional works · 3.8% of its workBiomedical Engineering: 14 fractional works · 1.4% of its workMechanical Engineering: 5 fractional works · 0.5% of its workIndustrial and Manufacturing Engineering: 5 fractional works · 0.5% of its workElectrical and Electronic Engineering: 4 fractional works · 0.4% of its workControl and Systems Engineering: 4 fractional works · 0.4% of its workComputational Mechanics: 2 fractional works · 0.2% of its workSmaller subfields together: 5 fractional works · 0.5% of its workComputer Science: 18 fractional works · 1.8% of its workArtificial Intelligence: 7 fractional works · 0.7% of its workComputer Vision and Pattern Recognition: 4 fractional works · 0.4% of its workComputational Theory and Mathematics: 3 fractional works · 0.3% of its workInformation Systems: 2 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.2% of its workEnvironmental Science: 18 fractional works · 1.8% of its workHealth, Toxicology and Mutagenesis: 4 fractional works · 0.4% of its workEnvironmental Chemistry: 2 fractional works · 0.2% of its workWater Science and Technology: 2 fractional works · 0.2% of its workEcology: 2 fractional works · 0.2% of its workSmaller subfields together: 7 fractional works · 0.7% of its workMathematics: 16 fractional works · 1.5% of its workStatistics and Probability: 15 fractional works · 1.5% of its workSmaller subfields together: 1 fractional works · 0.1% of its workChemistry: 13 fractional works · 1.3% of its workOrganic Chemistry: 4 fractional works · 0.4% of its workSpectroscopy: 4 fractional works · 0.4% of its workAnalytical Chemistry: 3 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workMaterials Science: 7 fractional works · 0.7% of its workMaterials Chemistry: 4 fractional works · 0.4% of its workSmaller subfields together: 3 fractional works · 0.3% of its workEnergy: 2 fractional works · 0.2% of its workPhysics and Astronomy: 2 fractional works · 0.2% of its workChemical Engineering: 1 fractional works · 0.1% of its workEarth and Planetary Sciences: 1 fractional works · 0.1% of its workSocial Sciences: 86 fractional works · 8.5% of its workEconomics, Econometrics and Finance: 35 fractional works · 3.4% of its workEconomics and Econometrics: 26 fractional works · 2.6% of its workFinance: 8 fractional works · 0.8% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 19 fractional works · 1.9% of its workSociology and Political Science: 7 fractional works · 0.7% of its workEducation: 5 fractional works · 0.5% of its workPolitical Science and International Relations: 3 fractional works · 0.3% of its workSmaller subfields together: 4 fractional works · 0.4% of its workBusiness, Management and Accounting: 10 fractional works · 1.0% of its workManagement of Technology and Innovation: 3 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 3 fractional works · 0.3% of its workStrategy and Management: 2 fractional works · 0.2% of its workSmaller subfields together: 2 fractional works · 0.2% of its workDecision Sciences: 9 fractional works · 0.9% of its workStatistics, Probability and Uncertainty: 4 fractional works · 0.4% of its workManagement Science and Operations Research: 3 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.1% of its workPsychology: 9 fractional works · 0.9% of its workClinical Psychology: 3 fractional works · 0.3% of its workSocial Psychology: 3 fractional works · 0.3% of its workSmaller subfields together: 3 fractional works · 0.3% of its workArts and Humanities: 5 fractional works · 0.5% of its workALL ITS WORKNovo Nordisk(Denmark)1,012fractional works, 2022-now
Life Sciences22%Physical Sciences11%Health Sciences58%Social Sciences9%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 26 fields, with their numbers
    1. Medicine54553.8%
    2. Health Professions323.2%
    3. Nursing50.5%
    4. Veterinary10.1%
    5. Dentistry00.0%
    1. Biochemistry, Genetics and Molecular Biology16416.2%
    2. Neuroscience242.3%
    3. Immunology and Microbiology181.8%
    4. Pharmacology, Toxicology and Pharmaceutics111.1%
    5. Agricultural and Biological Sciences101.0%
    1. Engineering383.8%
    2. Computer Science181.8%
    3. Environmental Science181.8%
    4. Mathematics161.5%
    5. Chemistry131.3%
    6. Materials Science70.7%
    7. Energy20.2%
    8. Physics and Astronomy20.2%
    9. Chemical Engineering10.1%
    10. Earth and Planetary Sciences10.1%
    1. Economics, Econometrics and Finance353.4%
    2. Social Sciences191.9%
    3. Business, Management and Accounting101.0%
    4. Decision Sciences90.9%
    5. Psychology90.9%
    6. Arts and Humanities50.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Novo Nordisk (Denmark) specialise in?

Where its research is concentrated relative to its size: Endocrinology, Diabetes and Metabolism takes 31.8× the share of its output that it takes of world research.

  1. Endocrinology, Diabetes and MetabolismSubfield · 174.6 works32×
  2. HematologySubfield · 32.6 works11×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 10 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.04× its world share, 164 worksBiochemistry, Geneti…Immunology and Microbiology: 1.79× its world share, 18 worksImmunology and Micro…Neuroscience: 1.44× its world share, 24 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.06× its world share, 11 worksPharmacology, Toxico…Chemical Engineering: 0.36× its world share, 1 worksChemical EngineeringChemistry: 0.83× its world share, 13 worksChemistryComputer Science: 0.23× its world share, 18 worksComputer ScienceEarth and Planetary Sciences: 0.06× its world share, 1 worksEarth and Planetary …Energy: 0.23× its world share, 2 worksEnergyEngineering: 0.25× its world share, 38 worksEngineeringEnvironmental Science: 0.36× its world share, 18 worksEnvironmental ScienceMaterials Science: 0.19× its world share, 7 worksMaterials ScienceMathematics: 1.31× its world share, 16 worksMathematicsPhysics and Astronomy: 0.07× its world share, 2 worksPhysics and AstronomyDentistry: 0.08× its world share, 0 worksDentistryHealth Professions: 1.20× its world share, 32 worksHealth ProfessionsMedicine: 2.80× its world share, 544 worksMedicineNursing: 1.04× its world share, 5 worksNursingVeterinary: 1.00× its world share, 1 worksVeterinaryArts and Humanities: 0.16× its world share, 5 worksArts and HumanitiesBusiness, Management and Accounting: 0.30× its world share, 10 worksBusiness, Management…Decision Sciences: 0.92× its world share, 9 worksDecision SciencesEconomics, Econometrics and Finance: 1.61× its world share, 35 worksEconomics, Econometr…Psychology: 0.28× its world share, 9 worksPsychologySocial Sciences: 0.15× its world share, 19 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 3.1×. Every wedge is a field page.

All 26 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics3.06×11 works
  2. Biochemistry, Genetics and Molecular Biology3.04×164 works
  3. Medicine2.80×544 works
  4. Immunology and Microbiology1.79×18 works
  5. Economics, Econometrics and Finance1.61×35 works
  6. Neuroscience1.44×24 works
  7. Mathematics1.31×16 works
  8. Health Professions1.20×32 works
  9. Nursing1.04×5 works
  10. Veterinary1.00×1 works
  11. Decision Sciences0.92×9 works
  12. Chemistry0.83×13 works
  13. Chemical Engineering0.36×1 works
  14. Environmental Science0.36×18 works
  15. Business, Management and Accounting0.30×10 works
  16. Psychology0.28×9 works
  17. Engineering0.25×38 works
  18. Computer Science0.23×18 works
  19. Energy0.23×2 works
  20. Agricultural and Biological Sciences0.20×10 works
  21. Materials Science0.19×7 works
  22. Arts and Humanities0.16×5 works
  23. Social Sciences0.15×19 works
  24. Dentistry0.08×0 works
  25. Physics and Astronomy0.07×2 works
  26. Earth and Planetary Sciences0.06×1 works

Who are the top researchers at Novo Nordisk (Denmark)?

Ranked on the quality score, Lotte Bjerre Knudsen, Charles Pyke and Søren Rasmussen lead among researchers whose main affiliation is Novo Nordisk (Denmark).

  1. 1 Lotte Bjerre Knudsen Denmark · #30,833 worldwide 16k citations · 145 works
  2. 2 Charles Pyke Denmark · #72,113 worldwide 10k citations · 124 works
  3. 3 Søren Rasmussen Denmark · #100,308 worldwide 7.8k citations · 134 works
  4. 4 Ludger Rose Denmark · #104,678 worldwide 5.3k citations · 64 works
  5. 5 Anna Secher Denmark · #145,156 worldwide 5.2k citations · 59 works
  6. 6 Helena W. Rodbard Denmark · #146,373 worldwide 13k citations · 168 works
  7. 7 Ole Kleist Jeppesen Denmark · #148,459 worldwide 5.8k citations · 54 works
  8. 8 Nicolai R. Wagtmann Denmark · #148,853 worldwide 6.4k citations · 58 works
  9. 9 Steffen Reedtz‐Runge Denmark · #159,950 worldwide 3.9k citations · 32 works
  10. 10 Krister B. Bokvist Denmark · #185,368 worldwide 8k citations · 95 works
All ranked researchers at Novo Nordisk (Denmark)

What are the most cited papers from Novo Nordisk (Denmark)?

The most cited paper from Novo Nordisk (Denmark) is "Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes" (Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al., 2016), with 7,629 citations. Next come "Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes" (6,902) and "Once-Weekly Semaglutide in Adults with Overweight or Obesity" (5,049).

Most cited papers
#PaperReleasedCitations
1 Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Steven P. Marso, Gilbert H. Daniels, Kirstine Brown‐Frandsen et al. · New England Journal of Medicine Open access 13 Jun 2016 7,629
2 Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Steven P. Marso, Stephen Charles Bain, Agostino Consoli et al. · New England Journal of Medicine Open access 16 Sep 2016 6,902
3 Once-Weekly Semaglutide in Adults with Overweight or Obesity John P.H. Wilding, Rachel Louise Batterham, Salvatore Calanna et al. · New England Journal of Medicine Open access 10 Feb 2021 5,049
4 The complete genome sequence of the Gram-positive bacterium Bacillus subtilis Frank Kunst et al. · Nature Open access151 authors Nov 1997 3,720
5 Epigenetic differences arise during the lifetime of monozygotic twins Mario Fernández Fraga et al. · Proceedings of the National Academy of Sciences Open access 11 Jul 2005 3,643
All 60 most cited papers, with filters and sorting

Which keywords describe research at Novo Nordisk (Denmark)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Type 2 Diabetes, Cardiovascular Disease, Obesity, Heart Failure, Diabetes and Clinical Guidelines.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control132▲ 82×4 topics
  2. Insulin Therapy125▲ 99×3 topics
  3. Type 2 Diabetes110▲ 48×6 topics
  4. Cardiovascular Disease106▲ 9.2×35 topics
  5. Obesity102▲ 13×23 topics
  6. Heart Failure98▲ 22×13 topics
  7. Diabetes96▲ 19×16 topics
  8. Clinical Guidelines81▲ 27×8 topics
  9. Cardiovascular Outcomes77▲ 133×1 topic
  10. Glucose Control77▲ 133×1 topic
  11. Metabolic Syndrome73▲ 8.9×18 topics
  12. Inflammation68▲ 3.2×66 topics
  13. Epidemiology56▲ 1.39×71 topics
  14. Insulin Resistance56▲ 12×10 topics
  15. Weight Loss48▲ 30×4 topics
  16. Type 1 Diabetes47▲ 55×2 topics
  17. Lifestyle Intervention46▲ 51×2 topics
  18. Complications38▲ 7.6×6 topics
  19. Continuous Glucose Monitoring37▲ 81×1 topic
  20. Hypoglycemia37▲ 81×1 topic
  21. Oxidative Stress37▲ 2.2×43 topics
  22. Atherosclerosis36▲ 12×11 topics
  23. Cardiovascular Risk34▲ 11×9 topics
  24. Health Outcomes31▲ 11×6 topics
  25. Clinical Trials28▲ 4.2×17 topics
  26. Diabetes Mellitus28▲ 13×6 topics
  27. Glucose Metabolism27▲ 27×2 topics
  28. Primary Care26▲ 7.0×11 topics
  29. Gene Therapy26▲ 13×6 topics
  30. Cholesterol24▲ 16×4 topics
  31. Bariatric Surgery24▲ 67×1 topic
  32. Metabolic Surgery24▲ 67×1 topic
  33. Global Prevalence22▲ 23×2 topics
  34. Alzheimer's Disease22▲ 7.9×7 topics
  35. Cancer Risk20▲ 9.0×5 topics
  36. Monoclonal Antibodies20▲ 22×3 topics
  37. Efficacy20▲ 24×2 topics
  38. Prophylaxis19▲ 15×3 topics
  39. Recombinant Factor VIIa19▲ 41×2 topics
  40. Inhibitors19▲ 46×2 topics

Which research topics does Novo Nordisk (Denmark) publish most on?

By volume in 2022-now: Diabetes Treatment and Management, Diabetes Management and Research, Bariatric Surgery and Outcomes and Diabetes, Cardiovascular Risks, and Lipoproteins.

Diabetes Treatment and M…77Diabetes Treatment and Management: 77 fractional worksDiabetes Management and …37Diabetes Management and Research: 37 fractional worksBariatric Surgery and Ou…24Bariatric Surgery and Outcomes: 24 fractional worksDiabetes, Cardiovascular Risks, and Lipoproteins: 22 fractional worksHemophilia Treatment and Research: 19 fractional worksMetabolism, Diabetes, an…18Metabolism, Diabetes, and Cancer: 18 fractional worksLiver Disease Diagnosis and Treatment: 15 fractional worksPancreatic function and diabetes: 15 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 14 fractional worksPharmacology and Obesity Treatment: 12 fractional works
Endocrinology, Diabetes and MetabolismSurgeryHematologyMolecular Biology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 77 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 37 works
  3. 3 Bariatric Surgery and Outcomes Surgery 24 works
  4. 4 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 22 works
  5. 5 Hemophilia Treatment and Research Hematology 19 works
  6. 6 Metabolism, Diabetes, and Cancer Molecular Biology 18 works
  7. 7 Liver Disease Diagnosis and Treatment Epidemiology 15 works
  8. 8 Pancreatic function and diabetes Surgery 15 works
  9. 9 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 14 works
  10. 10 Pharmacology and Obesity Treatment Pharmacology 12 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available41.3%not open58.7%

World: 40% of research is openly available.

with international co-authors44.2%domestic only55.8%

World: 18% is written across borders.

How has Novo Nordisk (Denmark)'s research output changed?

Output in 2022-2025 was 28% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Novo Nordisk (Denmark) as a percentage of every work published that year, 0.0041% in 2024.

still counting0.010%0.020%0.030%Novo Nordisk (Denmark)0.0050% in 202519801990200020102020

Fractional works of Novo Nordisk (Denmark) over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year, against all institutions in the same year.

still counting10%20%Novo Nordisk (Denmark)15.8% in 2025all institutions10.0% in 2025200020102020

Of each year's output, the share that reached the world's 10% most cited for its field and year. Peak 17.9% in 2021.

Other research institutions in Copenhagen

All research institutions in Copenhagen

Share Novo Nordisk (Denmark)'s ranking

Novo Nordisk (Denmark) on Science Explorer

A card with Novo Nordisk (Denmark)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website2Each links back here and updates with every snapshot

Its overall standing, then the domains, fields and subfields where Novo Nordisk (Denmark) is in the world's top ten or its top 1%. Each has an image of its own.

Overall

Domains

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Novo Nordisk (Denmark). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.